Shanghai Fosun Pharmaceutical (02196) Announces First Three Quarters Results: Net Profit Attributable to Shareholders RMB2.667 billion, Up 5.71% Year-on-Year
Shanghai Fosun Pharmaceutical (02196) announced its results for the first three quarters of 2026. The Group recorded operating revenue of RMB30.463 billion, up 3.64% year-on-year; net profit attributable to shareholders of the listed company was RMB2.667 billion, up 5.71% year-on-year; basic earnings per share were RMB1.01.
Shanghai Fosun Pharmaceutical (02196) announced its results for the first three quarters of 2026. The Group recorded operating revenue of RMB30.463 billion, up 3.64% year-on-year; net profit attributable to shareholders of the listed company was RMB2.667 billion, up 5.71% year-on-year; basic earnings per share were RMB1.01.
Related Articles
BASECARE-B (02170) repurchased 11,000 shares for HK$14,600 on October 27.
Sinotruk Jinan Truck (03808): Jinan Truck's net profit for the first three quarters was approximately RMB2.134 billion, up 43.69% year on year.
TOPNC (07688) repurchased 208,500 shares on October 27 for approximately HK$3.9743 million.
BASECARE-B (02170) repurchased 11,000 shares for HK$14,600 on October 27.
Sinotruk Jinan Truck (03808): Jinan Truck's net profit for the first three quarters was approximately RMB2.134 billion, up 43.69% year on year.
TOPNC (07688) repurchased 208,500 shares on October 27 for approximately HK$3.9743 million.
